Today's News | Note: News feeds may no longer be available for the articles on this page.

Biogen Idec Boosting MS Drugs in Late-Stage Tests 1:01 PM 3/25/2009
Bloomberg - USA
Biogen Idec Inc has 20 new medicines in advanced human trials. They include treatments for multiple sclerosis, cancer, and Parkinson’s disease. ...

GPC Biotech Seeks Lung Cancer Drug Partner Before Cash Runs Out 6:42 AM 3/25/2009
Bloomberg - USA
GPC Biotech AG combined with Agennix Inc last month and now looks for partner for the experimental talactoferrin cancer drug before cash runs out in 2010. ...

Novartis-Antisoma lung cancer drug tested in Japan 5:32 AM 3/25/2009
Reuters - USA
Clinical trials of experimental lung cancer drug ASA404 being developed by Novartis AG and Antisoma Plc have been extended to Japan. They're evaluating ASA404 as a first-line treatment for non-small cell lung cancer. ...

Pfizer Seeks Partner After Bone Drug Gains Approval in Europe 5:33 PM 3/24/2009
Bloomberg - USA
Pfizer Inc gained approval from European regulators to sell Fablyn (lasofoxifene tartrate) for women with weak bones. It seeks a partner to market the drug. Ligand Pharmaceuticals Inc developed the therapy. ...

Cubist suing Teva in patent dispute 4:22 PM 3/24/2009
Forbes - NY,USA
Cubist Pharmaceuticals Inc is suing Teva Pharmaceutical Industries over the antibiotic Cubicin patents which expire in 2016 and 2019. ...

Biogen acquires option for Aveo cancer drug rights 3:00 PM 3/24/2009
Reuters - USA
Biogen Idec Inc acquired an option to license the rights to certain experimental cancer drugs being developed by Aveo Pharmaceuticals Inc including ErbB3-targeted antibodies. ...

Q+A: What can be done about drug-resistant TB? 11:02 AM 3/24/2009
Reuters - USA
The World Health Organization reported that extensively drug-resistant tuberculosis (XDR-TB) has spread to 55 countries and territories worldwide. ...

Celsion drug candidate gets special FDA status 10:02 AM 3/24/2009
Forbes - NY,USA
Celsion Corp said that the US FDA granted orphan drug status to its developing treatment for liver cancer. ...

Biogen Tests Malaria Drug for Tysabri Brain Infection 9:01 AM 3/24/2009
Bloomberg - USA
Biogen Idec Inc may have a treatment for the deadly brain infections linked to multiple sclerosis drug Tysabri. A malaria drug is being tested by Biogen on patients with progressive multifocal leukoencephalopathy (PML). ...

Judge Orders FDA to make Plan B Pill Available to 17-Year-Olds 4:57 PM 3/23/2009
New York Times - United States
A federal judge ordered the US FDA to make the Plan B morning-after birth control pill available without prescription to women under 18. ...

Watson Pharmaceuticals to voluntarily recall drug 1:27 PM 3/23/2009
Forbes - NY,USA
Watson Pharmaceuticals Inc is voluntarily recalling Propafenone HCl 225 milligram tablets in 100-count bottles. The pills contain more of the active ingredient than specified. ...

SkyePharma files key asthma drug for FDA approval 8:37 AM 3/23/2009
Reuters - USA
SkyePharma Plc has submitted its asthma drug Flutiform for approval with the US FDA. Flutiform is the most important product in the company's pipeline with potential sales of $500 million a year. ...

Rivals benefit from generic drugmaker setbacks 1:50 PM 3/22/2009
Reuters - USA
Actavis, KV Pharmaceutical Co, Caraco Pharmaceutical Laboratories, and Sandoz have all been cited for problems by the US FDA. Others manufacturers pick up the slack. ...

Drug industry hopes for FDA split 6:14 AM 3/22/2009
Los Angeles Times - CA,USA
It makes little sense that the same agency regulates drugs like Vioxx and peanut butter (two recent failures). But what to call them? ...

Appeals Court Revives Some Patent Rules Attacked By Glaxo 1:21 PM 3/21/2009
CNNMoney.com - USA
A federal appeals court revived certain controversial new rules aimed at curbing abuse of the US patent system. It could reduce the backlog of unexamined patent applications. ...

<- Day Earlier | Today's News